home 2018-04-13T09:58:50+00:00

We are a proud member of Certara, the global leader in model-informed drug development and regulatory science.
Together we are driving impactful science from bench to market. Learn more

How can we help you?

VALUE + ACCESS

Our value and access teams provide a full range of market access services in an integrated model.
We combine strong technical capabilities in real-world evidence development, health-economic analysis
and advanced analytic methods with our deep relationships in the payer/HTA community.

DECISION ANALYTICS + MODELLING

Leveraging best-in-class capabilities in modelling, simulation, mathematics and Bayesian statistics,
Analytica Laser employs advanced analytics frameworks and proprietary software
to study and predict real world outcomes for drug value assessment.

REAL WORLD EVIDENCE SERVICES

Drawing on decades of experience with a wide variety of real-world data sources,
we can offer solutions for every need: from niche needs identification, justifying access to differentiating value and quantifying opportunities.
Our real world evidence services and proprietary data sets are trusted by decision-makers and healthcare leaders across the world.

| Why Us?

As a global leader in population health intelligence, we’re committed to providing the highest level of scientific evidence on the real-world value of medicines and health technologies. Every day our work directly benefits millions of patients in advancing access to new therapies that are safer, more convenient and more affordable.

Our group is widely considered to be a pioneer in leveraging evidence-based methodologies in health systems throughout Europe, North America and MEA. Our regional teams excel at assessing the value of medicines and health technologies through an unmatched combination of research expertise, sophisticated analytics, public health intelligence, health economics and decades of experience in pricing and market access strategy.

Analytica Laser is part of Certara, the global leader in model-informed drug development and regulatory science. Our joint mission is to change the game in drug development and patient access, providing healthcare leaders with unparalleled end-to-end strategy and cutting-edge technology to define, capture, and communicate value —from R&D intelligence all the way to patient care.

| We help you assess and demonstrate value from early development to post-launch commitments.

Therapeutic Areas of Expertise and Special Populations

analytica-laser

Global Presence

With offices across Europe & North America and an unparalleled international network, Analytica Laser is well-positioned to provide strategic consulting and scientific research services to the global health care industry. Our consulting, research and data solutions are currently employed by the leading biopharma and public health innovators in over 20 countries. Together with our colleagues at Certara, our work has unparalleled global reach.

New YorkMontrealLondonMadridParisLorrachMilanKrakow

Insights

News

Twitter

  • analytica-laser
News

Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions

Acquisition adds real-world effectiveness prediction and value assessment to Certara’s model-informed drug development and regulatory science decision-making portfolio PRINCETON, NJ – Apr. 12, 2018 – Certara®, the global leader in model-informed drug development Read more >

Certara breaks into real-world value services with Analytica Laser buy: Fierce Biotech reports. https://t.co/uu9pWXj7OE

We are looking for a junior statistician/statistical analyst within our real-world data analytics team in the New York Office. Strategic growth opportunity, check out the profile for more details and apply today! https://t.co/a4CXPcOYe6

We’re excited to announce that Analytica Laser has joined Certara, the global leader in model-informed drug development. Providing unparalleled end-to-end strategy and cutting-edge technology — from R&D intelligence all the way to patient access. More: https://t.co/Jgaw28vLpi

@kemartin611 You asked at @npc today, where US would stand if social service spending was accounted for in costs: According to the data, b/w Norway and Germany on 9th, not 1st place. #healthspending

Load More...

Conferences & Events

  • analytica-laser
Webinars

Analytica’s M. Brougham on Future Trends in HTA

See a video of Matthew Brougham (Senior Consultant at Laser Analytica) and Amir Tahami (Director of Market Access and Read more >

  • analytica-laser
Webinars

Analytica Laser’s Drivers of Effectiveness featured in IMI initiative

On 18 April 2016, leaders from IMI GetReal met at the Takeda offices in London for a live broadcast: “Introduction to the Read more >